---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-050120"
form_type: "8-K"
ticker: "USAQ"
cik: "0000856984"
company_name: "QHSLab, Inc."
filed_at: "2024-12-16T23:59:59+00:00"
generated_at: "2026-05-29T03:12:50.128706+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# QHSLab projects $10M revenue with 250-300 physicians at >65% gross margins

## Summary
- Single provider using full suite can generate $30-50k annual revenue for QHSLab.
- Allergy kits ~$100/test; immunotherapy ~$500/patient/year; digital tools $20-40/patient.
- Targeting 250-300 physicians to drive over $10M annual revenue at >65% gross margins.
- Paid $215k to Mercer debt from cashflow; plans to eliminate debt with new capital.
- Expanding sales force by 5 reps in TX, GA, NY; QHS Behavioral Centers by Q2 2025.

## SEC filing metadata
- accession: 0001493152-24-050120
- form_type: 8-K
- ticker: USAQ
- cik: 0000856984
- company_name: QHSLab, Inc.
- filed_at: 2024-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856984/000149315224050120/0001493152-24-050120-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856984/000149315224050120/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-050120
- JSON: https://secwatch.observer/filing/0001493152-24-050120.json
- Plain text: https://secwatch.observer/filing/0001493152-24-050120.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.